Skip to main content
. 2007 Mar 30;78(10):1124–1128. doi: 10.1136/jnnp.2006.110726

Table 2 Trial appreciation.

HAMLET (n = 28) (n (%)) PAIS (n = 30) (n (%)) p Value
Was the information provided clear to you?*
 Yes 27 (96) 14 (47) <0.001
 No 0 (0) 1 (3)
 Don't know 1 (4) 15 (50)
Did you perceive the outcome of treatment allocation as a matter of life or death?*
 Yes 23 (82) 10 (33) 0.001
 No 4 (14) 16 (54)
 Don't know 1 (4) 4 (13)
Do you have negative feelings about the informed consent procedure?*
 Yes 9 (32) 1 (3) 0.014
 No 18 (64) 28 (94)
 Don't know 1 (4) 2 (3)
Do you feel that the question for participation and randomisation was acceptable at that moment?
 Yes 19 (68) 16 (54) 0.40
 No 4 (14) 4 (13)
 Don't know 5 (18) 10 (33)
Were you capable of deciding about participation?*
 Yes 17 (61) 13 (43) 0.018
 No 8 (29) 4 (14)
 Don't know 3 (10) 13 (43)
Did you feel participation was voluntary?
 Yes 18 (65) 23 (77) 0.18
 No 8 (28) 3 (10)
 Don't know 2 (7) 4 (13)
Do you regret having given permission?
 Yes 3 (11) 0 (0) 0.12
 No 23 (82) 25 (83)
 Don't know 2 (7) 5 (17)
Are you glad with the treatment your relative received?
 Yes 14 (50) 19 (63) 0.17
 No 5 (18) 7 (23)
 Don't know 9 (32) 4 (13)
Would you have preferred the doctor having taken the responsibility for treatment choices?
 Yes 11 (39) 6 (20) 0.12
 No 15 (54) 17 (57)
 Don't know 2 (7) 7 (23)
Would you have preferred the doctor having taken the responsibility for study participation?
 Yes 3 (11) 0 (0) 0.063
 No 21 (75) 20 (67)
 Don't know 4 (14) 10 (33)
Would you approve participation again under similar circumstances?
 Yes 17 (61) 20 (67) 0.78
 No 2 (7) 1 (3)
 Don't know 9 (32) 9 (30)
How do you feel about being interviewed again?
 Positive 23 (82) 23 (77) 0.49
 Negative 3 (11) 2 (7)
 Neutral 2 (7) 5 (17)

HAMLET, Hemicraniectomy After Middle cerebral artery infarction with Life‐threatening Edema Trial; PAIS, Paracetamol (Acetaminophen) In Stroke trial.

*Statistically significant difference between HAMLET and PAIS.